Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and may associate with malignancy risk in long-t... by Bottomley, MJ, Harden, PN, Wood, KJ, Hester, J, Issa, F

CD45RA identifies TSDR demethylated regulatory T cells with a stable phenotype and suppressive cytokine profile by Hornero, RA, Betts, GJ, Sawitzki, B, Vogt, K, Harden, PN, Wood, KJ

Regulatory cell therapy in kidney transplantation (The ONE Study): A harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials by Sawitzki, B, Harden, PN, Reinke, P, Hester, JL, Issa, F, Morris, PJ, Bushell, A, Friend, PJ, Wood, KJ

Late treatment with autologous expanded regulatory T-cell therapy after alemtuzumab induction is safe and facilitates immunosuppression minimization in living donor renal transplan... by Brook, MO, Hennessy, C, Hester, J, Hammad, S, Alzhrani, A, Rombach, I, Dutton, S, Lombardi, G, Wood, KJ, Friend, P, Harden, PN, Issa, F

Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials by Sawitzki, B, Harden, PN, Reinke, P, Roberts, ISD, Hester, J, van der Net, JB, Petchey, W, Issa, F, Morris, PJ, Bushell, A, Friend, P, Wood, K, Geissler, EK, Et al.

Feasibility, long‐term safety and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients by Harden, PN, Game, D, Sawitzki, B, Van der Net, J, Hester, J, Bushell, A, Issa, F, Brook, MO, Alzhrani, A, Schlickeiser, S, Scotta, C, Petchey, W, Blancho, G, Tang, Q, Markmann, J, Lechler, RI, Roberts, IR, Friend, P, Hilton, R, Geissler, EK, Wood, KJ, Lombardi, G